118 related articles for article (PubMed ID: 36778347)
1. Ataxin-2 polyglutamine expansions aberrantly sequester TDP-43, drive ribonucleoprotein condensate transport dysfunction and suppress local translation.
Wijegunawardana D; Vishal SS; Venkatesh N; Gopal PP
bioRxiv; 2023 Feb; ():. PubMed ID: 36778347
[TBL] [Abstract][Full Text] [Related]
2. ALS-associated ataxin 2 polyQ expansions enhance stress-induced caspase 3 activation and increase TDP-43 pathological modifications.
Hart MP; Gitler AD
J Neurosci; 2012 Jul; 32(27):9133-42. PubMed ID: 22764223
[TBL] [Abstract][Full Text] [Related]
3. Distinct TDP-43 pathology in ALS patients with ataxin 2 intermediate-length polyQ expansions.
Hart MP; Brettschneider J; Lee VM; Trojanowski JQ; Gitler AD
Acta Neuropathol; 2012 Aug; 124(2):221-30. PubMed ID: 22526021
[TBL] [Abstract][Full Text] [Related]
4. Phase separation and pathologic transitions of RNP condensates in neurons: implications for amyotrophic lateral sclerosis, frontotemporal dementia and other neurodegenerative disorders.
Naskar A; Nayak A; Salaikumaran MR; Vishal SS; Gopal PP
Front Mol Neurosci; 2023; 16():1242925. PubMed ID: 37720552
[TBL] [Abstract][Full Text] [Related]
5. Sequence Determinants of TDP-43 Ribonucleoprotein Condensate Formation and Axonal Transport in Neurons.
Vishal SS; Wijegunawardana D; Salaikumaran MR; Gopal PP
Front Cell Dev Biol; 2022; 10():876893. PubMed ID: 35646935
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the prevalence of polyglutamine repeat expansions in amyotrophic lateral sclerosis.
Lee T; Li YR; Chesi A; Hart MP; Ramos D; Jethava N; Hosangadi D; Epstein J; Hodges B; Bonini NM; Gitler AD
Neurology; 2011 Jun; 76(24):2062-5. PubMed ID: 21562248
[TBL] [Abstract][Full Text] [Related]
7. Motor neurone disease/amyotrophic lateral sclerosis associated with intermediate-length CAG repeat expansions in Ataxin-2 does not have 1C2-positive polyglutamine inclusions.
Highley JR; Lorente Pons A; Cooper-Knock J; Wharton SB; Ince PG; Shaw PJ; Wood J; Kirby J
Neuropathol Appl Neurobiol; 2016 Jun; 42(4):377-89. PubMed ID: 26095883
[TBL] [Abstract][Full Text] [Related]
8. Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients.
Lee T; Li YR; Ingre C; Weber M; Grehl T; Gredal O; de Carvalho M; Meyer T; Tysnes OB; Auburger G; Gispert S; Bonini NM; Andersen PM; Gitler AD
Hum Mol Genet; 2011 May; 20(9):1697-700. PubMed ID: 21292779
[TBL] [Abstract][Full Text] [Related]
9. Ataxin-1 and ataxin-2 intermediate-length PolyQ expansions in amyotrophic lateral sclerosis.
Conforti FL; Spataro R; Sproviero W; Mazzei R; Cavalcanti F; Condino F; Simone IL; Logroscino G; Patitucci A; Magariello A; Muglia M; Rodolico C; Valentino P; Bono F; Colletti T; Monsurrò MR; Gambardella A; La Bella V
Neurology; 2012 Dec; 79(24):2315-20. PubMed ID: 23197749
[TBL] [Abstract][Full Text] [Related]
10. Ataxin-2 interacts with FUS and intermediate-length polyglutamine expansions enhance FUS-related pathology in amyotrophic lateral sclerosis.
Farg MA; Soo KY; Warraich ST; Sundaramoorthy V; Blair IP; Atkin JD
Hum Mol Genet; 2013 Feb; 22(4):717-28. PubMed ID: 23172909
[TBL] [Abstract][Full Text] [Related]
11. The modulation of Amyotrophic Lateral Sclerosis risk by ataxin-2 intermediate polyglutamine expansions is a specific effect.
Gispert S; Kurz A; Waibel S; Bauer P; Liepelt I; Geisen C; Gitler AD; Becker T; Weber M; Berg D; Andersen PM; Krüger R; Riess O; Ludolph AC; Auburger G
Neurobiol Dis; 2012 Jan; 45(1):356-61. PubMed ID: 21889984
[TBL] [Abstract][Full Text] [Related]
12. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS.
Elden AC; Kim HJ; Hart MP; Chen-Plotkin AS; Johnson BS; Fang X; Armakola M; Geser F; Greene R; Lu MM; Padmanabhan A; Clay-Falcone D; McCluskey L; Elman L; Juhr D; Gruber PJ; Rüb U; Auburger G; Trojanowski JQ; Lee VM; Van Deerlin VM; Bonini NM; Gitler AD
Nature; 2010 Aug; 466(7310):1069-75. PubMed ID: 20740007
[TBL] [Abstract][Full Text] [Related]
13. [Conjoint pathological cascades mediated by RNA-binding proteins, TDP-43, FUS and ataxin-2].
Ito D
Rinsho Shinkeigaku; 2012; 52(11):1221-3. PubMed ID: 23196570
[TBL] [Abstract][Full Text] [Related]
14. Amyotrophic lateral sclerosis-linked mutations increase the viscosity of liquid-like TDP-43 RNP granules in neurons.
Gopal PP; Nirschl JJ; Klinman E; Holzbaur EL
Proc Natl Acad Sci U S A; 2017 Mar; 114(12):E2466-E2475. PubMed ID: 28265061
[TBL] [Abstract][Full Text] [Related]
15. TDP-43 pathology in polyglutamine diseases: with reference to amyotrphic lateral sclerosis.
Toyoshima Y; Takahashi H
Neuropathology; 2014 Feb; 34(1):77-82. PubMed ID: 23889603
[TBL] [Abstract][Full Text] [Related]
16. C9orf72 hexanucleotide repeat expansions and Ataxin 2 intermediate length repeat expansions in Indian patients with amyotrophic lateral sclerosis.
Narain P; Gomes J; Bhatia R; Singh I; Vivekanandan P
Neurobiol Aging; 2017 Aug; 56():211.e9-211.e14. PubMed ID: 28527524
[TBL] [Abstract][Full Text] [Related]
17. Altered mRNP granule dynamics in FTLD pathogenesis.
Bowden HA; Dormann D
J Neurochem; 2016 Aug; 138 Suppl 1():112-33. PubMed ID: 26938019
[TBL] [Abstract][Full Text] [Related]
18. Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin-2 to induce motor neuron dysfunction and cell death.
Sellier C; Campanari ML; Julie Corbier C; Gaucherot A; Kolb-Cheynel I; Oulad-Abdelghani M; Ruffenach F; Page A; Ciura S; Kabashi E; Charlet-Berguerand N
EMBO J; 2016 Jun; 35(12):1276-97. PubMed ID: 27103069
[TBL] [Abstract][Full Text] [Related]
19. Ataxin-2 polyQ expansions in FTLD-ALS spectrum disorders in Flanders-Belgian cohorts.
Van Langenhove T; van der Zee J; Engelborghs S; Vandenberghe R; Santens P; Van den Broeck M; Mattheijssens M; Peeters K; Nuytten D; Cras P; De Deyn PP; De Jonghe P; Cruts M; Van Broeckhoven C
Neurobiol Aging; 2012 May; 33(5):1004.e17-20. PubMed ID: 22035589
[TBL] [Abstract][Full Text] [Related]
20. TDP-43 levels in the brain tissue of ALS cases with and without
Yang Y; Halliday GM; Kiernan MC; Tan RH
Neurology; 2019 Nov; 93(19):e1748-e1755. PubMed ID: 31619481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
